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Abstract The pleckstrin homology and C2 domains are
modular protein structures involved in mediating intermolecular
interactions. Although they represent distinct domains, there are
several parallels regarding their function and type of interactions
in which they participate. Both domains are stable structural
entities that incorporate variable regions which, in different
proteins, can be adapted to perform a specific function through
binding to membrane phospholipids or specific protein ligands. A
number of recent examples illustrate the function of some of
these domains in regulated membrane attachment, with an
important role in many cellular signalling pathways.
z 1999 Federation of European Biochemical Societies.
1. Introduction
The concept that modular domains act as mediators of
distinct intermolecular interactions has been central to our
understanding of a variety of cellular processes and, in partic-
ular, cellular signalling. Two such domains, the pleckstrin
homology (PH) and the C2 domain, were originally identi¢ed
in pleckstrin and protein kinase C (PKC), respectively. Sub-
sequently, they have been identi¢ed in a large number of other
proteins [1,2]. During the past 5 years, both domains have
been the focus of extensive studies and frequent reviews
(e.g. [3^7]). Here, we describe how recent structural studies
on these domains together with the identi¢cation of a range
of lipid and protein ligands by in vitro and cellular studies
have provided new insights into the possible functions of these
domains. Many examples have been provided from studies of
phospholipases (phospholipases C (PLCs) and cytoplasmic
phospholipase A2 (cPLA2)) that incorporate both of these
domains.
2. Structure and structural basis for ligand binding in PH and
C2 domains
A number of structures of PH domains (recently reviewed
in [3]) and several structures of C2 domains [8^11] have been
solved. In both cases, despite a low sequence similarity, the
structure of each domain represents a well-de¢ned and con-
served structural entity (Fig. 1). The structure of all PH do-
mains is an electrostatically polarized antiparallel L-sheet
sandwich, one containing four L-stands and the other three,
closed at one end with a C-terminal K-helix (Fig. 1, left panel).
Variable loops connecting the L-strands (shown in magenta)
participate in the formation of a ligand binding surface. The
general structure of the C2 domains is an eight-stranded anti-
parallel L-sandwich, made up of two four-stranded L-sheets,
connected by variable loops (Fig. 1, right panel). Loops at one
end of the domain (shown in magenta) vary signi¢cantly in
sequence and length and, like the loop region of the PH do-
main, contain residues that are involved in ligand binding.
Variability of these loop regions allows these stable structures
to incorporate speci¢c features and interact with di¡erent li-
gands or to coordinate the same ligand in several di¡erent
ways. Interactions with the best-characterized ligands, the
headgroup of inositol lipids for PH domains and calcium
ions for C2 domains, are shown in Fig. 1. Inositol-lipid bind-
ing by the PH domains and calcium-dependent phospholipid
binding by the C2 domains can both mediate interactions with
cellular membranes. However, other ligands and functions for
ligand binding have been suggested for these modular struc-
tures. These are generally less well understood.
Structural requirements of PH domain interactions with an
inositol lipid headgroup have been studied using inositol
phosphate as a mimic of the cytoplasm-exposed moiety of
the membrane bound phosphoinositides. For example, inosi-
tol (1,4,5)-trisphosphate (Ins(1,4,5)P3) has been used to repre-
sent the headgroup of phosphatidylinositol (4,5)-bisphosphate
(PtdIns(4,5)P2). On the basis of NMR data in the presence
and absence of the ligand [12-16] and crystal structures in a
complex with Ins(1,4,5)P3 [17,18], the ligand binding site has
been determined for a number of the PH domains. In PLCN1,
Ins(1,4,5)P3 is bound between loops L-1/2 and L-3/4 (Fig. 1).
A similar position is likely to be occupied by this ligand in
several other PH domains (e.g. dynamin, SOS1, pleckstrin and
L-adrenergic receptor kinase (L-ARK)) although basic resi-
dues in each of these PH domains involved in Ins(1,4,5)P3
binding are not strictly conserved. However, a di¡erent part
of the L-spectrin PH domain, the region between loops L-1/2
and L-5/6, coordinates binding of Ins(1,4,5)P3. This is unlikely
to be artefactual since the same site has been determined by
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crystallographic and NMR studies. The binding site for ino-
sitol (1,3,4,5)-tetrakisphosphate (Ins(1,3,4,5)P4), approximat-
ing the headgroup of the phosphoinositide 3 kinase (PI-3
kinase) product phosphatidylinositol (3,4,5)-trisphosphate
(PtdIns(3,4,5)P3), has been structurally de¢ned in the case of
Bruton’s tyrosine kinase [19], preferentially binding this ino-
sitol phosphate and the corresponding inositol lipid. Together
with mutational analysis of PtdIns(3,4,5)P3 binding to the Btk
PH domain [20] this has demonstrated that the binding site is
analogous to that of PLC N1. A screen for the PH domains
that could speci¢cally bind to lipids produced by PI-3 kinase
in Saccharomyces cerevisiae [21] identi¢ed several PH domains
already implicated in these interactions by in vitro studies (e.g.
protein kinase B, product of the Akt gene (PKB/Akt) [22,23],
Btk [20]) as well as new PH domains. Comparison of the
sequences of these proteins suggests that residues which de-
termine speci¢c high a⁄nity binding for the ligand could be
conserved and therefore form a structurally similar binding
pocket. However, conformation of this hypothesis by struc-
tural studies is required.
In addition to binding of inositol lipids or phosphates, the
PH domains and the structurally related phosphotyrosine
binding (PTB) domains are also involved in protein/protein
interactions. Structural studies of the interaction of PTB do-
mains with their protein ligands, exempli¢ed by the interac-
tion of the adaptor protein Shc with a NGF receptor peptide,
revealed the involvement of the loop region in phosphotyro-
sine binding (reviewed in [4]). Recently, a binding domain for
small GTPase Ran (RanBD1) has been shown to be closely
related to PTB/PH domains, with the loop region involved in
interactions with the ‘switch region’ of Ran [24]. Other pro-
tein/protein interactions described for PH domains include
binding of GLQ subunits by L-ARK [25,26] and GK12 by
Btk and Ras GTPase activating protein (GAP) (GAP1m)
[27]. However, these interactions are not entirely mediated
by the PH domains and are likely to involve adjacent regions.
Structural insights into calcium binding properties of sev-
eral C2 domains have also been obtained. Comparison of C2
domain/calcium complexes revealed binding of multiple calci-
um ions in C2 domains from synaptotagmin I C2A (synI
C2A) [28], cPLA2 [9], PKCL [10] and PLCN1 [29] by acidic
residues in two or three of the calcium binding loop regions
(designated as CBR1, CBR2 and CBR3 in [9]). Together with
mutagenesis and direct binding studies, positions of up to four
potential binding sites have been suggested (designated I^IV
in [10]). However, not all positions seem to be occupied by
calcium in di¡erent C2 domains and the residues that could
coordinate calcium at a particular position are not present in
all structures determined. Calcium binding could lead to the
binding of a third ligand (reviewed in [7]), which in case of
synI C2A, PKC and cPLA2 has been demonstrated to be a
phospholipid. The ternary complex formation may not result
from calcium-triggered conformational changes. It is more
likely to be formed through stabilization of an ‘open’ confor-
mation and/or electrostatic changes due to calcium binding to
acidic residues within the C2 domain. Clearly, further study is
required to investigate the identity of residues and type of
interactions that can determine phospholipid binding. Some
Fig. 1. Structure of the PH (left) and C2 (right) domains from PLCN1. Structures are ribbon diagrams with inositol trisphosphate (ball and
stick) bound to the PH domain and calcium (spheres) to the C2 domain.
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information has been obtained from studies of synI C2A [30]
and cPLA2 [31,32], demonstrating that CBRs can penetrate
the lipid bilayer. In the case of cPLA2, the residues critical for
lipid binding have been identi¢ed as exposed hydrophobic
residues, distinct from residues that coordinate calcium ions.
C2 domains are also involved in calcium-dependent and
calcium-independent protein/protein interactions (reviewed in
[6,7]). In the case of synaptotagmins, a number of protein/
protein interactions have been described (see below). Recent
studies of some of these interactions using mutagenesis [33]
suggested that sites of protein/protein interactions are likely to
include CBRs and other parts (e.g. concave region formed by
L-strands) of the C2 domain.
3. PH and C2 domains as determinants of regulated membrane
interactions
Studies of the PH domain binding to a range of inositol
lipids and phosphates now available revealed large di¡erences
in the a⁄nity and degree of binding speci¢city for di¡erent
PH domains [34,35]. However, these studies do not re£ect true
binding properties (in particular a⁄nities) of these domains in
all cases, since the environment provided by natural mem-
branes is not easy to reconstruct in vitro. Nonetheless, studies
using methods where interaction with cellular membranes can
be monitored demonstrated that some speci¢c/high a⁄nity
ligands in vitro are also likely to be cellular ligands. A number
of studies on PH domain-dependent cellular localization have
been performed (e.g. [36^38]). In addition, a system has been
designed to select PH domains that can bind to the plasma
membrane (in the presence or absence of activated PI-3 kin-
ase) based on their ability to rescue the growth of temperature
sensitive S. cerevisiae [21]. Studies of the PLCN1 PH domain
have demonstrated a high a⁄nity and relative speci¢city for
PtdIns(4,5)P2 and Ins(1,4,5)P3 but can also bind Ins(1,3,4,5)P4
and PtdIns(3,4,5)P3. Since PtdIns(4,5)P2 is present in cells in
higher concentrations than PtdIns(3,4,5)P3, it has been re-
garded as a physiologically important ligand and further stud-
ies of membrane binding provided clear evidence that this is
indeed the case. In the yeast rescue assay [21], the PLCN1 PH
domain supported growth in the presence of only
PtdIns(4,5)P2 in the membrane, i.e. it did not require co-ex-
pression with PI-3 kinase. Studies where the wild-type and
PLCN1 with mutations in the PH domain were compared
for the ability to bind Ins(1,4,5)P3 in vitro and to interact
with membranes of MDCK cells after microinjection demon-
strated that the PH domain is essential and su⁄cient for
membrane attachment and that the loss of headgroup binding
in vitro correlates with the loss of membrane attachment [39].
Furthermore, using a PLCN1 PH domain-green £uorescent
protein (GFP) fusion protein, it was possible to visualize
changes in membrane interactions in non-stimulated and
stimulated RBL, MDCK and NIH 3T3 cells ([40^42]), respec-
tively. While in non-stimulated cells, the PH domain was as-
sociated with the membrane, stimulation (e.g. stimulation of
NIH3T3 cells by angiotensin II [42]) leading to PtdIns(4,5)P2
hydrolysis and a signi¢cant reduction of PtdIns(4,5)P2 con-
centrations (directly measured in [42]) resulted in a detach-
ment of the PLCN1 PH domain from the membrane. The
detachment was transient and was restored following
PtdIns(4,5)P2 synthesis (Fig. 2A). These experiments not
only demonstrated that PtdIns(4,5)P2 is an in vivo ligand
for the PLCN1 PH domain but also supported the possibility
that changes in the concentration of this ligand can regulate
membrane interactions.
Several PH domains can speci¢cally bind products of PI-3
kinase in vitro (e.g. PH domains from Btk [20], PKB/Akt
[22,23], ARF nucleotide binding site opener (ARNO) [43]).
Some of these PH domains (Btk, PKB/Akt) were analyzed
in the yeast rescue assay [21] and found to bind membranes
and thus support growth only when PI-3 kinase was intro-
duced into the cells. Studies of cellular localization further
con¢rmed that PtdIns(3,4,5)P3 and PtdIns(3,4)P2 could act
as ligands for the PH domains, when synthesized in cells after
stimulation. Using GFP fusion constructs of ARNO (a mem-
ber of the exchange factor family for ARFs), it has been
shown that in 3T3 L1 adipocytes, insulin causes a rapid PH
domain-dependent translocation from cytoplasm to the plas-
ma membrane [44]. The translocation was prevented by inhib-
itors of PI-3 kinase (wortmannin and LY294002) and the
dominant negative mutant of this enzyme. This suggests that
the membrane binding is a consequence of PI-3 kinase acti-
vation and the rapid and transient accumulation of its inositol
lipid products that can interact with the ARNO PH domain
(Fig. 2B). Although correlation of in vitro binding data and
cellular studies have been shown for several PH domains, this
is not always the case. For example, studies of the Ras ex-
changer son of sevenless (Sos) demonstrated that the ability of
the PH domain to interact with the membrane does not cor-
relate with its ability to bind PtdIns(4,5)P2 [45].
The use of similar experimental approaches supported a
role for some C2 domains in calcium-regulated membrane
targeting. Well-studied examples include C2 domains from
cPLA2 [32], PKCQ [46] and PKCK [47]. Localization studies
of cPLA2 or its isolated C2 domain [32] demonstrated that in
non-stimulated cells, these proteins are present in the cyto-
Fig. 2. Examples of regulated membrane interactions mediated by
the PH and C2 domains: detachment of PLCN1 from the plasma
membrane following agonist-triggered PIP2 hydrolysis [40] (A), plas-
ma membrane association of ARNO following stimulation of PI-3
kinase [44] (B) and association of cPLA2 with internal membranes
following addition of a calcium ionophore [32] (C).
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plasm. After addition of a calcium ionophore and a conse-
quent increase in the intracellular calcium concentrations, the
cPLA2-GFP constructs translocated to internal cellular mem-
branes (endoplasmic reticulum and nuclear membrane) (Fig.
2C). Similar data have been obtained for PKCQ-GFP or iso-
lated PKCQ C2-GFP. In this case, addition of a calcium ion-
ophore or antigen stimulation of RBL cells resulted in trans-
location to the plasma membrane [46]. Following antigen
stimulation, which causes repetitive calcium spikes, it was
also possible to demonstrate oscillations of the PKCQ trans-
location to the membrane which were synchronous with
changes in calcium concentrations. These cellular studies
therefore con¢rm previous in vitro observations of calcium-
triggered phospholipid binding by C2 domains.
4. Versatile functions of PH and C2 domains
The role of PH and C2 domains in determining the regu-
lated membrane localization, that requires high a⁄nity and
speci¢city of ligand binding, has only been established for
some of a vast number of proteins containing these domains.
Many PH domains, for example, have low a⁄nities for ino-
sitol lipids and it is likely that these weak interactions could
contribute to the membrane localization of a protein, medi-
ated by another domain. In the case of pleckstrin, the pres-
ence of the PH domain is not su⁄cient to mediate membrane
attachment which also requires phosphorylation on Ser and
Thr residues outside this domain [38]. It has recently been
suggested that PH domains from PLCL1 and PLCL2 can
strongly interact with surfaces composed only of neutral lipids
and thus mediate non-speci¢c membrane interactions which
cannot be regulated by the ligand concentrations [48]. There
are also several reports that C2 domains mediate phospholipid
binding which is calcium-independent. Examples include the
PKC Apl I [49] and PI-3 kinase C2L [50].
It is becoming clear, however, that a view of PH and C2
domains merely as devices for recruitment to the membrane is
too simplistic. Evidence obtained from studies of Ser/Thr kin-
ase PKB/Akt suggests that binding to products of activated
PI-3 kinase not only mediates membrane interactions but is
also likely to trigger critical conformational changes of the
protein which allow phosphorylation of Ser and Thr residues
by other kinases (PDK1 and PDK2). Phosphorylation of
these residues outside the PH domain is critical for activation
of PKB/Akt activity (reviewed in [51]). Modulation of enzy-
matic activity through PH domain-phosphoinositide interac-
tions has also been demonstrated for Vav, a guanine nucleo-
tide exchange factor of Rac [52]. The exchange factor activity
is a property of the adjacent DH domain and binding of
PtdIns(4,5)P2 to the PH domain inhibits while binding of
PtdIns(3,4,5)P3 stimulates the activity of the DH domain. In
addition to this direct allosteric e¡ect, binding of
PtdIns(3,4,5)P3 also increases the phosphorylation of Vav by
tyrosine kinase Lck and in this way contributes towards Vav
activation. The structure of the DH/PH region from other
exchange factors, Sos [53] and LPIX [54], demonstrated that
although the two domains could communicate, the surface
area of PH/DH interaction is poorly conserved among di¡er-
ent DH/PH proteins. Therefore, the relative disposition of the
two domains may not allow a change, caused by the PH
domain ligand binding, to a¡ect the function of the DH do-
main in all DH/PH containing proteins.
Recent studies have also indicated that binding of inositol
phosphates to some PH domains may not just re£ect their
ability to interact with the inositol lipid headgroups but could
itself have physiological relevance. The binding a⁄nity of
Ins(1,4,5)P3 to the PLCN1 PH domain (210 nM) is higher
than for PtdIns(4,5)P2 (1.7 WM) and competition between
the ligands could contribute to membrane detachment when
Ins(1,4,5)P3 is produced in cells following stimulation [55].
The PH domain of GAP1IP4BP, puri¢ed as IP4 binding protein
with Ras-GAP activity, has about a 10-fold higher a⁄nity for
Ins(1,3,4,5)P4 than for PtdIns(3,4,5)P3 derivatives and shows
a much lower binding of other inositol phosphates and inosi-
tol lipids (reviewed in [56]). It is possible that inositol-poly-
phosphate binding to this, and probably some other PH do-
mains, could have important physiological consequences.
Function(s) of Ins(1,3,4,5)P4 binding to GAP1IP4BP, however,
remain(s) unclear. It could be required for enhancement of the
GAP activity towards Ras or it functions could be related to
IP4-regulated calcium entry [56].
A number of protein/protein interactions have been re-
ported to be mediated by the PH and C2 domains. Although
some of the protein binding partners are membrane compo-
nents and the interaction can be regarded as indirect mem-
brane binding, functional consequences of these protein/pro-
tein interaction are speci¢c and governed by the properties of
interacting proteins. Examples of PH/PTB domains as inter-
action sites with speci¢c proteins have been discussed above.
A broad spectrum of protein ligands has been described for
the C2 domains where interactions could be constitutive or
regulated in a calcium-dependent fashion (reviewed in [6]).
Many of these interactions have been described for synapto-
tagmin isoforms and are believed to be important for their
function in regulated vesicle transport (synaptic transmission,
exo- and endocytosis), by mediating formation of protein
complexes. For example, synaptotagmins can interact with
syntaxin, a plasma membrane protein critical in the exocytosis
of synaptic vesicles, in a calcium-dependent manner [57,58].
However, the interaction of the C2B domain in most synap-
totagmin isoforms with clathrin adaptor protein-2, involved in
coated pit assembly, is calcium-independent [57,59]. Protein
interactions mediated by C2 domains are not restricted to
synaptotagmins. Other examples include rabphilin-3A binding
to the cytoskeletal protein L-adducin in the presence of cal-
cium and phospholipid [60] and interaction of C2 domains
from PKC with receptors for activated C kinase [61].
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